WO2002020562A3 - Family member of inhibitor of apoptosis proteins - Google Patents

Family member of inhibitor of apoptosis proteins Download PDF

Info

Publication number
WO2002020562A3
WO2002020562A3 PCT/EP2001/010011 EP0110011W WO0220562A3 WO 2002020562 A3 WO2002020562 A3 WO 2002020562A3 EP 0110011 W EP0110011 W EP 0110011W WO 0220562 A3 WO0220562 A3 WO 0220562A3
Authority
WO
WIPO (PCT)
Prior art keywords
inhibitor
family member
apoptosis proteins
polypeptides
iapl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/010011
Other languages
French (fr)
Other versions
WO2002020562A2 (en
Inventor
Bernd Hentsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to JP2002525181A priority Critical patent/JP2004508032A/en
Priority to AU2001284046A priority patent/AU2001284046A1/en
Priority to EP01962987A priority patent/EP1315810A2/en
Priority to CA002421187A priority patent/CA2421187A1/en
Priority to US10/363,137 priority patent/US20040039185A1/en
Publication of WO2002020562A2 publication Critical patent/WO2002020562A2/en
Publication of WO2002020562A3 publication Critical patent/WO2002020562A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

IAPL-2 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing IAPL-2 polypeptides and polynucleotides in diagnostic assays.
PCT/EP2001/010011 2000-09-06 2001-08-30 Family member of inhibitor of apoptosis proteins Ceased WO2002020562A2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2002525181A JP2004508032A (en) 2000-09-06 2001-08-30 A new family member of inhibitors of apoptosis proteins
AU2001284046A AU2001284046A1 (en) 2000-09-06 2001-08-30 Family member of inhibitor of apoptosis proteins
EP01962987A EP1315810A2 (en) 2000-09-06 2001-08-30 Family member of inhibitor of apoptosis proteins
CA002421187A CA2421187A1 (en) 2000-09-06 2001-08-30 Family member of inhibitor of apoptosis proteins
US10/363,137 US20040039185A1 (en) 2000-09-06 2001-08-30 Novel family member of inhibitor of apoptosis proteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00119271.5 2000-09-06
EP00119271 2000-09-06

Publications (2)

Publication Number Publication Date
WO2002020562A2 WO2002020562A2 (en) 2002-03-14
WO2002020562A3 true WO2002020562A3 (en) 2003-01-03

Family

ID=8169764

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/010011 Ceased WO2002020562A2 (en) 2000-09-06 2001-08-30 Family member of inhibitor of apoptosis proteins

Country Status (6)

Country Link
US (1) US20040039185A1 (en)
EP (1) EP1315810A2 (en)
JP (1) JP2004508032A (en)
AU (1) AU2001284046A1 (en)
CA (1) CA2421187A1 (en)
WO (1) WO2002020562A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062943A2 (en) * 1998-06-02 1999-12-09 Millenium Pharmaceuticals, Inc. Novel molecules of the aip-related protein family and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062943A2 (en) * 1998-06-02 1999-12-09 Millenium Pharmaceuticals, Inc. Novel molecules of the aip-related protein family and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 13 September 1999 (1999-09-13), ROBERT STRAUSBERG: "UI-H-BI0-aan-f-08-0-UI.s1 NCI_CGAP_Sub1 Homo sapiens cDNA clone", XP002217261, retrieved from EBI Database accession no. AW015743 *
DATABASE EMBL [online] 29 April 1997 (1997-04-29), HILLIER L. ET AL.: "zu62a05.s1 Soares_testis_NHT Homo sapiens cDNA clone IMAGE:742544 3' similar to TR:G1184318 G1184318 INHIBITOR OF APOPTOSIS PROTEIN 2 ; mRNA sequence", XP002217262, retrieved from EBI Database accession no. AA400037 *

Also Published As

Publication number Publication date
EP1315810A2 (en) 2003-06-04
CA2421187A1 (en) 2002-03-14
WO2002020562A2 (en) 2002-03-14
AU2001284046A1 (en) 2002-03-22
US20040039185A1 (en) 2004-02-26
JP2004508032A (en) 2004-03-18

Similar Documents

Publication Publication Date Title
HK1053840A1 (en) Novel compounds
WO2001066690A3 (en) Novel compounds
WO2001072961A3 (en) Novel compounds
WO2001004141A3 (en) Seripancrin
WO2001083744A3 (en) Natrium-calcium exchanger protein
WO2002008253A3 (en) A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
WO2002020562A3 (en) Family member of inhibitor of apoptosis proteins
WO2002004600A3 (en) Novel compounds
WO2002012274A3 (en) Iapl-3 a protein inhibitor of apoptosis proteins
WO2001083771A3 (en) Human phospholipase c delta 5
WO2001068816A8 (en) Human histamine h3 gene variant-3
EP0890646A3 (en) HE2NW40 Serine Protease
WO2001079269A3 (en) Lipid binding protein 4
WO1999038885A3 (en) Sbsemvl polypeptides, being members of the semaphorin protein family, and polynucleotides encoding the same
WO2001085937A3 (en) Regulator of g protein signalling (rgs8)
WO2001055428A3 (en) Mprot45 metalloprotease
WO2002014355A3 (en) Novel mitogen activated kinase
WO2001077147A3 (en) New bromodomain protein
WO2001085921A3 (en) Human serine-threonine kinase-4
WO2002008252A3 (en) Novel protein containing ring finger domaine r1p4
WO2001079492A3 (en) Lipid binding protein 3
WO2001062779A3 (en) New transcription factor carp-2
WO2001077150A3 (en) Serine-threonine kinase
WO2001068703A8 (en) Human histamine h3 gene variant-2
WO2001072963A3 (en) Novel human uridine kinase

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2001962987

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2421187

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2002525181

Country of ref document: JP

Ref document number: 10363137

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2001284046

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 2001962987

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2001962987

Country of ref document: EP